Search Result "natalizumab."
Is β-catenin neutralization cross-involved in the mechanisms mediated by natalizumab action?
Journal: Current Molecular Medicine
Volume: 15 Issue: 10 Year: 2015 Page: 990-993
Author(s): M. Galuppo,E. Mazzon,S. Giacoppo,O. Bereshchenko,S. Bruscoli,C. Riccardi,P. Bramanti
The Matrix Metalloproteinases Panel in Multiple Sclerosis Patients Treated with Natalizumab: A Possible Answer to Natalizumab Non- Responders
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17 Issue: 6 Year: 2018 Page: 464-472
Author(s): Rodica Balasa,Ciurba Bianca,Voidezan Septimiu,Simu Iunius,Hutanu Adina,Andone Sebastian,Romaniuc Andreea,Motataianu Anca,Maier Smaranda
A Review on Clinical Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Natalizumab: A Humanized Anti-α4 Integrin Monoclonal Antibody
Journal: Current Drug Metabolism
Volume: 19 Issue: 14 Year: 2018 Page: 1213-1223
Author(s): Hao Li,Fang-Hong Shi,Shi-Ying Huang,Shun-Guo Zhang,Min-Ling Chen
Natalizumab Modifies Catecholamines Levels Present in Patients with Relapsing- Remitting Multiple Sclerosis
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 3 Year: 2016 Page: 4876-4880
Author(s): Begona M. Escribano, Macarena Aguilar-Luque, Carmen Bahamonde, Cristina Conde, Rafael Lillo, Fernando Sanchez-Lopez, Ana I. Giraldo, Antonio H. Cruz, Evelio Luque, Felix Gascon, Eduardo Aguera, Isaac Tunez
Natalizumab Changes the Peripheral Profile of the Th17 Panel in MS Patients: New Mechanisms of Action
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16 Issue: 9 Year: 2017 Page: 1018-1026
Author(s): Rodica Ioana Balasa,Mihaela Simu,Septimiu Voidazan,Laura Iulia Barcutean,Zoltan Bajko,Adina Hutanu,Iunius Simu,Smaranda Maier
Real-World Data Regarding Long-Term Administration of NatalizumabDerived from a Neurology Department along with Literature Review
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 21 Issue: 4 Year: 2022 Page: 326-334
Author(s): Eugenia Irene Davidescu,Irina Odajiu,Constantin-DragoÈ Sandu,Amalia Ghergu,Dimela Luca,Dafin Fior MureÈanu,Bogdan Ovidiu Popescu
Survey of Latin American Neuroimmunologists on the Treatment of Multiple Sclerosis with Monoclonal Antibodies
Journal: Current Drug Safety
Volume: 10 Issue: 3 Year: 2015 Page: 217-220
Author(s): Yara Dadalti Fragoso
Monoclonal Antibodies in the Treatment of Multiple Sclerosis
Journal: Current Medicinal Chemistry
Volume: 16 Issue: 3 Year: 2009 Page: 4858-4868
Author(s): F. Di Pauli, T. Berger, M. Reindl
Therapeutic Monitoring of Immunotherapies in Autoimmune Diseases
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4550-4555
Author(s): Nicolas von Ahsen,Andrew Chan
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4513-4517
Author(s): Karl Vass